[Abstract Only] Observational Study: Men with Prostate Cancer and Pre-existing CV Comorbidities Have Increased Mortality Risk Following Oral Antiandrogen Therapy

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities – European Urology (link to abstract – $ for full-text)

Commentaries: CVD Prior to Oral Antiandrogen Therapy for Prostate Cancer Increases Mortality Risk – Cancer Therapy Advisor (free) AND Risks of Novel Oral Prostate Cancer Therapies and Pre-existing Conditions – Thomas Jefferson University (free)